Hoag Memorial Hospital Presbyterian

Hoag Memorial Hospital Presbyterian was paid $21.30M by Medicaid between Jan 2018 and Dec 2024, across 388 billing codes. Its largest line is 0450, Emergency room services — 9.0% of everything it billed.

33Billing provider infoHOAG MEMORIAL HOSPITAL PRESBYTERIAN
NEWPORT BEACH, CA 92663

33aNPI1518951300assigned 09/07/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$21.30M

24GClaims1,454,296

24DCodes billed388

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#117 of 410

Median peer was paid$6.90M

This provider vs. median3.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	189,245	$1.78M
2019	192,167	$2.55M
2020	206,633	$2.68M
2021	256,006	$3.63M
2022	277,381	$3.89M
2023	230,354	$4.04M
2024incomplete	102,510	$2.73M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	9.0%	134,937	114,163	$1.91M
74177	Computed tomography, abdomen and pelvis; with contrast material	6.5%	10,873	9,626	$1.38M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	4.5%	32,512	25,982	$961K
78815	Positron emission tomography (PET) for limited area imaging	3.6%	1,440	1,316	$767K
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	3.4%	20,841	15,456	$727K
80053	Comprehensive metabolic panel	3.3%	108,738	89,972	$697K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	3.0%	12,278	10,598	$643K
70450	Computed tomography, head or brain; without contrast material	2.7%	12,119	10,958	$567K
96375	Therapeutic injection; each additional sequential IV push	2.4%	25,552	18,516	$513K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.4%	13,126	10,478	$501K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.3%	107,878	88,323	$487K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	2.0%	39,877	34,674	$429K

376 more codes

74176	Computed tomography, abdomen and pelvis; without contrast material	2.0%	6,264	$429K
71275	Computed tomographic angiography, chest, with contrast material	1.7%	2,990	$369K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.6%	23,313	$347K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.3%	1,953	$270K
72125	Computed tomography, cervical spine; without contrast material	1.2%	3,580	$256K
J9271	Injection, pembrolizumab, 1 mg	1.2%	48	$254K
96361	Intravenous infusion, hydration; each additional hour	1.2%	19,509	$250K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	8,253	$249K
76700	Ultrasound, abdominal, real time with image documentation; complete	1.2%	6,117	$246K
93976		1.1%	3,146	$239K
93971		1.0%	3,188	$215K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	6,019	$180K
99199	Unlisted special service, procedure or report	<1%	3,631	$180K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,352	$179K
71045	Radiologic examination, chest; single view	<1%	23,504	$179K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,449	$177K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,535	$177K
J7030	Infusion, normal saline solution , 1000 cc	<1%	27,637	$177K
71046	Radiologic examination, chest; 2 views	<1%	13,779	$174K
76830	Ultrasound, transvaginal	<1%	3,746	$172K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,675	$171K
93970		<1%	1,488	$164K
99283	Emergency room visit (moderate)	<1%	9,462	$153K
J3490	Unclassified drugs	<1%	19,362	$152K
84484		<1%	27,805	$146K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,953	$146K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,768	$145K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	7,410	$139K
77066	Tomosynthesis, mammo	<1%	1,501	$139K
G0378	Hospital observation service, per hour	<1%	834	$138K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,323	$138K
Z9725		<1%	3,113	$133K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,325	$126K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	6,475	$108K
88307		<1%	986	$100K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	25,659	$99K
J1170	Injection, hydromorphone, up to 4 mg	<1%	14,426	$95K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	934	$95K
71250		<1%	2,211	$93K
76642		<1%	1,861	$92K
59025	Fetal non-stress test	<1%	5,146	$87K
76801		<1%	1,901	$87K
83690		<1%	23,901	$87K
J1815	Injection, insulin, per 5 units	<1%	2,772	$85K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,828	$84K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,162	$82K
Z7502		<1%	2,399	$76K
97139		<1%	3,133	$73K
99284	Emergency room visit (serious)	<1%	8,085	$68K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	15,966	$68K
83880		<1%	5,305	$66K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	2,955	$63K
70549		<1%	372	$61K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	3,609	$59K
70496		<1%	406	$58K
76770		<1%	1,788	$57K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	9,451	$56K
84703		<1%	22,549	$55K
73564		<1%	3,026	$52K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	2,851	$51K
36430		<1%	1,114	$51K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,514	$51K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	8,007	$51K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,638	$50K
J7050	Infusion, normal saline solution, 250 cc	<1%	15,444	$50K
C1769	Guide wire	<1%	1,349	$50K
70498		<1%	411	$49K
96367		<1%	1,877	$48K
73610		<1%	3,246	$48K
73630		<1%	3,423	$48K
0270		<1%	49,592	$47K
73030		<1%	3,248	$47K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,486	$46K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	397	$45K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,120	$45K
90715		<1%	2,127	$44K
99285	Emergency room visit (most serious)	<1%	3,509	$44K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,852	$44K
J2704	Injection, propofol, 10 mg	<1%	6,164	$43K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,395	$40K
84145		<1%	3,509	$40K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,193	$39K
88341		<1%	836	$39K
77065	Tomosynthesis, mammo	<1%	505	$39K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	8,356	$38K
81001		<1%	24,128	$38K
97750		<1%	1,075	$37K
81025		<1%	2,782	$37K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	8,636	$36K
73110		<1%	2,446	$35K
72100		<1%	2,106	$35K
70486		<1%	536	$33K
73130		<1%	2,431	$33K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	6,983	$32K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,415	$31K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,412	$31K
74178		<1%	290	$30K
84443	Thyroid stimulating hormone (TSH)	<1%	3,798	$30K
83735		<1%	8,816	$29K
J2060	Injection, lorazepam, 2 mg	<1%	7,400	$29K
93798		<1%	2,563	$28K
75574		<1%	211	$28K
82962		<1%	12,860	$27K
J0690	Injection, cefazolin sodium, 500 mg	<1%	4,550	$27K
83605		<1%	5,191	$27K
96376		<1%	10,070	$27K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	7,464	$26K
85027		<1%	7,829	$25K
87040		<1%	3,514	$24K
85379		<1%	4,396	$23K
77386		<1%	142	$23K
73502		<1%	1,486	$22K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	757	$22K
74174		<1%	102	$21K
77334		<1%	128	$21K
88360		<1%	287	$21K
0160		<1%	2,647	$21K
80048	Basic metabolic panel (calcium, ionized)	<1%	6,098	$20K
J1453	Injection, fosaprepitant, 1 mg	<1%	218	$20K
72141		<1%	278	$20K
70544		<1%	529	$19K
76641		<1%	307	$19K
77063	Screening digital breast tomosynthesis, bilateral	<1%	457	$19K
77336		<1%	504	$18K
87086	Culture, bacterial; quantitative colony count, urine	<1%	4,946	$18K
73080		<1%	1,227	$18K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	4,853	$17K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,961	$17K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	756	$17K
80305		<1%	2,396	$16K
87077		<1%	3,545	$15K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,140	$15K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	201	$15K
85610		<1%	8,623	$15K
0762		<1%	781	$15K
88342		<1%	1,278	$14K
84702		<1%	2,465	$14K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	534	$14K
76870		<1%	434	$14K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	3,909	$13K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	3,569	$13K
72131		<1%	265	$13K
81003		<1%	12,014	$13K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	219	$13K
77049		<1%	40	$13K
93880		<1%	164	$13K
76536		<1%	468	$13K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,031	$12K
0360		<1%	3,536	$12K
88304		<1%	872	$12K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	711	$12K
73562		<1%	992	$11K
0250		<1%	7,411	$11K
80061	Lipid panel	<1%	1,568	$11K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,961	$10K
36415	Collection of venous blood by venipuncture	<1%	22,246	$10K
87081		<1%	3,617	$10K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	516	$10K
87186		<1%	2,568	$10K
96417		<1%	336	$10K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,716	$10K
73140		<1%	1,253	$10K
70491		<1%	99	$9K
12001		<1%	1,275	$9K
99070		<1%	1,244	$9K
86923		<1%	652	$9K
74018		<1%	952	$9K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	869	$9K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	657	$9K
97162		<1%	785	$8K
Z7610		<1%	577	$8K
10060		<1%	871	$8K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,249	$8K
85730		<1%	3,196	$7K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	615	$7K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	995	$7K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	2,563	$7K
12011		<1%	772	$7K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	42	$6K
73590		<1%	491	$6K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,875	$6K
96415		<1%	171	$6K
77300		<1%	77	$6K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	55	$6K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	149	$6K
86140		<1%	2,218	$6K
A9270	Non-covered item or service	<1%	11,922	$6K
87070		<1%	1,648	$5K
86901		<1%	4,192	$5K
99499		<1%	112	$5K
J1644	Injection, heparin sodium, per 1000 units	<1%	1,555	$5K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,860	$5K
86900		<1%	4,199	$5K
S0164	Injection, pantoprazole sodium, 40 mg	<1%	516	$5K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	23	$5K
82550		<1%	1,230	$4K
73090		<1%	400	$4K
72072		<1%	231	$4K
77080		<1%	153	$4K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	32	$4K
82805		<1%	304	$4K
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	138	$4K
L4386	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	70	$3K
84439		<1%	798	$3K
A4648	Tissue marker, implantable, any type, each	<1%	166	$3K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,355	$3K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	174	$3K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	415	$3K
0370		<1%	3,243	$3K
87205		<1%	1,862	$3K
86850		<1%	2,763	$3K
V5008	Hearing screening	<1%	115	$3K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	190	$3K
86304		<1%	492	$3K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	223	$3K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	31	$3K
72040		<1%	153	$3K
85652		<1%	1,659	$2K
86308		<1%	836	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	953	$2K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,075	$2K
82077		<1%	273	$2K
J1940	Injection, furosemide, up to 20 mg	<1%	626	$2K
J8540	Dexamethasone, oral, 0.25 mg	<1%	267	$2K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	46	$2K
73700		<1%	28	$2K
85046		<1%	785	$2K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	20	$2K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	68	$2K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	345	$2K
0272		<1%	2,266	$2K
J0153	Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)	<1%	72	$2K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,378	$2K
J1230	Injection, methadone hcl, up to 10 mg	<1%	115	$2K
82570		<1%	494	$1K
71270		<1%	25	$1K
12002		<1%	159	$1K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	276	$1K
72128		<1%	14	$1K
73660		<1%	153	$1K
0710		<1%	3,025	$1K
86922		<1%	78	$1K
83615		<1%	424	$1K
72110		<1%	54	$1K
36569		<1%	36	$1K
84100		<1%	471	$1K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	878	$1K
29125		<1%	389	$1K
71010		<1%	250	$1K
J1171	Injection, hydromorphone, 0.1 mg	<1%	153	$1K
J2800	Injection, methocarbamol, up to 10 ml	<1%	132	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	146	$1K
83550		<1%	339	$1K
82728		<1%	267	$974.82
C1729	Catheter, drainage	<1%	12	$957.17
88112		<1%	65	$955.44
82378		<1%	189	$907.01
86780		<1%	89	$896.89
J3480	Injection, potassium chloride, per 2 meq	<1%	292	$870.32
93017		<1%	29	$855.98
83540		<1%	342	$854.09
88173		<1%	26	$842.68
J1836	Injection, metronidazole, 10 mg	<1%	203	$831.91
97116		<1%	420	$820.35
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	82	$801.73
87088		<1%	393	$759.25
J1953	Injection, levetiracetam, 10 mg	<1%	56	$755.08
76819	Fetal biophysical profile; without non-stress testing	<1%	13	$739.46
C9113	Injection, pantoprazole sodium, per vial	<1%	162	$727.56
88331		<1%	25	$678.42
73060		<1%	57	$605.76
87486		<1%	42	$588.49
87581		<1%	42	$588.49
84550		<1%	289	$587.20
76882		<1%	16	$482.97
86803		<1%	38	$475.20
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	24,553	$469.04
0636		<1%	1,146	$453.07
85007		<1%	324	$417.38
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	12	$417.06
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	137	$409.96
0760		<1%	605	$385.92
80179		<1%	43	$380.24
J9045	Injection, carboplatin, 50 mg	<1%	16	$364.05
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	40	$355.97
A4217	Sterile water/saline, 500 ml	<1%	84	$352.14
Q3014	Telehealth originating site facility fee	<1%	99	$342.81
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	59	$324.92
88172		<1%	25	$260.27
73552		<1%	24	$259.42
84156		<1%	115	$253.23
80320		<1%	388	$249.23
87075		<1%	71	$246.07
0271		<1%	206	$236.49
J1630	Injection, haloperidol, up to 5 mg	<1%	340	$230.53
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	42	$229.23
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	12	$216.64
80143		<1%	44	$212.05
72170		<1%	25	$210.77
76942		<1%	13	$206.07
87340		<1%	32	$200.70
29515		<1%	56	$200.14
36591		<1%	64	$196.28
76098		<1%	13	$187.27
J1810	Injection, droperidol and fentanyl citrate, up to 2 ml ampule	<1%	166	$186.10
82607		<1%	55	$184.39
81002		<1%	338	$168.99
J2469	Injection, palonosetron hcl, 25 mcg	<1%	16	$162.77
J3411	Injection, thiamine hcl, 100 mg	<1%	35	$149.75
J2470	Injection, pantoprazole sodium, 40 mg	<1%	36	$148.17
87210		<1%	57	$146.71
J0456	Injection, azithromycin, 500 mg	<1%	23	$144.33
86592		<1%	30	$105.09
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	26	$92.57
82043		<1%	13	$78.21
82248		<1%	18	$65.54
36600		<1%	57	$60.55
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	12	$55.18
99153	Mod sedat endo service >5yrs	<1%	14	$44.72
85045		<1%	44	$37.23
83935		<1%	12	$36.15
99152		<1%	15	$35.78
84300		<1%	12	$26.35
89051		<1%	12	$25.08
29130		<1%	12	$16.80
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	87	$13.94
82272		<1%	16	$12.21
87420		<1%	18	$9.33
J1956	Injection, levofloxacin, 250 mg	<1%	12	$1.58
0637		<1%	280	$0.43
0390		0%	18	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	226	$0.00
0412		0%	18	$0.00
0351		0%	142	$0.00
0320		0%	353	$0.00
0480		0%	32	$0.00
0921		0%	79	$0.00
0300		0%	1,525	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	197	$0.00
80301		0%	192	$0.00
0278		0%	14	$0.00
0402		0%	358	$0.00
0403		0%	35	$0.00
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	0%	13	$0.00
0750		0%	19	$0.00
84112		0%	54	$0.00
0260		0%	241	$0.00
0510		0%	78	$0.00
0940		0%	74	$0.00
0302		0%	88	$0.00
0361		0%	26	$0.00
0343		0%	27	$0.00
J7510	Prednisolone oral, per 5 mg	0%	12	$0.00
94729		0%	12	$0.00
0324		0%	337	$0.00
0612	Calcium glucon (wg critical)	0%	33	$0.00
0761		0%	69	$0.00
0352		0%	137	$0.00
0401		0%	41	$0.00
59050		0%	77	$0.00
0301		0%	1,667	$0.00
0306		0%	297	$0.00
80329		0%	185	$0.00
0350		0%	246	$0.00
0335		0%	97	$0.00
0258		0%	178	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	13	$0.00
0610		0%	21	$0.00
27502		0%	13	$0.00
0305		0%	636	$0.00
27610		0%	16	$0.00
0307		0%	103	$0.00
0404		0%	22	$0.00
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	0%	63	$0.00
0310		0%	68	$0.00
0611		0%	33	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBRAITHWAITE, ROBERT (PRESIDENT/CEO)